Table 8 Stem cell donor type used for patients having received HSCT
| Â | 2021 | 2018 | 2013 | % change (%) |
|---|---|---|---|---|
MRD | ||||
 US | 290 | 229 | 76 | 281.6 |
 INT’L | 1624 | 1103 | 472 | 244.1 |
 Global | 1914 | 1332 | 548 | 249.3 |
MUD | ||||
 US | 535 | 362 | 151 | 254.3 |
 INT’L | 1483 | 1162 | 544 | 172.6 |
 Global | 2018 | 1524 | 695 | 190.4 |
mMUD | ||||
 US | 160 | 138 | 29 | 451.7 |
 INT’L | 302 | 211 | 134 | 125.4 |
 Global | 462 | 349 | 163 | 183.4 |
Parental haplo | ||||
 US | 218 | 126 | 57 | 282.5 |
 INT'L | 906 | 727 | 372 | 143.5 |
 Global | 1124 | 853 | 429 | 162.0 |
Total | ||||
 US | 1203 | 855 | 313 | 284.3 |
 INT'L | 4315 | 3203 | 1522 | 183.5 |
 Global | 5518 | 4058 | 1835 | 200.7 |